{"References": [{"title": "Mechanisms of resistance to CAR T cell therapy", "authors": "Majzner RG, Mackall CL", "journal": "Nature Reviews Clinical Oncology", "year": "2019", "volumes": "16", "first page": "372", "last page": "385", "DOI": "10.1038/s41571-019-0184-6"}, {"title": "Overcoming the challenges associated with CD3+ T-cell redirection in cancer", "authors": "Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A, Sadelain M", "journal": "British Journal of Cancer", "year": "2021", "volumes": "124", "first page": "1037", "last page": "1048", "DOI": "10.1038/s41416-020-01225-5"}, {"title": "CAR T cell immunotherapy for human cancer", "authors": "June CH, Sadelain M", "journal": "Science", "year": "2018", "volumes": "359", "first page": "1361", "last page": "1365", "DOI": "10.1126/science.aar6711"}, {"title": "Engineering strategies to overcome the current roadblocks in CAR T cell therapy", "authors": "Sterner RC, Sterner RM", "journal": "Nature Reviews Clinical Oncology", "year": "2021", "volumes": "18", "first page": "363", "last page": "379", "DOI": "10.1038/s41571-021-00476-2"}, {"title": "Resistance mechanisms to CAR-T cell therapy: lessons from lymphoma", "authors": "Frey NV, Porter DL", "journal": "Leukemia", "year": "2020", "volumes": "34", "first page": "341", "last page": "353", "DOI": "10.1038/s41375-019-0665-8"}, {"title": "CAR T cell therapy: inroads to response and resistance", "authors": "Cherkassky L, Morello A, Villena-Vargas J, Feng Y, Dimitrov DS, Jones DR, Sadelain M, Adusumilli PS", "journal": "Nature Reviews Immunology", "year": "2016", "volumes": "16", "first page": "741", "last page": "755", "DOI": "10.1038/nri.2016.108"}, {"title": "Tumor immune escape mechanisms that operate during metastasis", "authors": "Joyce JA, Fearon DT", "journal": "Cancer Immunology Research", "year": "2015", "volumes": "3", "first page": "1", "last page": "9", "DOI": "10.1158/2326-6066.CIR-14-0214"}, {"title": "The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma", "authors": "Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A, Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M, Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson M, Golub TR, Getz G, Rodig SJ, Shipp MA", "journal": "Cancer Cell", "year": "2018", "volumes": "33", "first page": "481", "last page": "499", "DOI": "10.1016/j.ccell.2018.03.005"}, {"title": "Chimeric antigen receptor T cells for sustained remissions in leukemia", "authors": "Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA", "journal": "New England Journal of Medicine", "year": "2014", "volumes": "371", "first page": "1507", "last page": "1517", "DOI": "10.1056/NEJMoa1407222"}, {"title": "Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia", "authors": "Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH", "journal": "New England Journal of Medicine", "year": "2018", "volumes": "378", "first page": "439", "last page": "448", "DOI": "10.1056/NEJMoa1709866"}]}